Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kronn

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Archives of Internal Medicine|April 29, 1998
Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NYD Kronn, V Jansen, H Ostrer
Neurology|April 1, 1996
Schwannomatosis: a clinical and pathologic studyM MacCollin, W Woodfin, D Kronn, et al.
American Journal of Medical Genetics|September 14, 1999
Characterization of a complex chromosomal rearrangement in a patient with a typical catlike cry and no other clinical findings of cri-du-chat syndromeC Sreekantaiah, D Kronn, R C Marinescu, et al.
American Journal of Human Genetics|December 18, 1997
Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosisL B Jacoby, D Jones, K Davis, et al.
Neurology|June 13, 2001
MeCP2 mutations in children with and without the phenotype of Rett syndromeK Hoffbuhr, J M Devaney, B LaFleur, et al.
Molecular Genetics and Metabolism|March 1, 2015
Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelinesB H Vogel, S E Bradley, D J Adams, et al.
Clinical Genetics|January 24, 2017
Association of the missense variant p.Arg203Trp in PACS1 as a cause of intellectual disability and seizuresD Stern, M T Cho, R Chikarmane, et al.
Molecular Genetics and Metabolism|September 11, 2012
Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disordersM Mokhtarani, G A Diaz, W Rhead, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Archives of Internal Medicine|April 29, 1998
Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NYD Kronn, V Jansen, H Ostrer
Neurology|April 1, 1996
Schwannomatosis: a clinical and pathologic studyM MacCollin, W Woodfin, D Kronn, et al.
American Journal of Medical Genetics|September 14, 1999
Characterization of a complex chromosomal rearrangement in a patient with a typical catlike cry and no other clinical findings of cri-du-chat syndromeC Sreekantaiah, D Kronn, R C Marinescu, et al.
American Journal of Human Genetics|December 18, 1997
Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosisL B Jacoby, D Jones, K Davis, et al.
Neurology|June 13, 2001
MeCP2 mutations in children with and without the phenotype of Rett syndromeK Hoffbuhr, J M Devaney, B LaFleur, et al.
Molecular Genetics and Metabolism|March 1, 2015
Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelinesB H Vogel, S E Bradley, D J Adams, et al.
Clinical Genetics|January 24, 2017
Association of the missense variant p.Arg203Trp in PACS1 as a cause of intellectual disability and seizuresD Stern, M T Cho, R Chikarmane, et al.
Molecular Genetics and Metabolism|September 11, 2012
Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disordersM Mokhtarani, G A Diaz, W Rhead, et al.
Pageof 1